P. Jones (London, United Kingdom), G. Sybrecht (Homburg/Saar, Germany)
The six-minute walk test as predictor factor in the long-term mortality in patients with COPD
C. Casanova, C. G. Cote, J. M. Marin, V. Pinto-Plata, C. Vassaux, J. P. De Torres, A. Aguirre-Jaime, B. R. Celli (Santa Cruz de Tenerife, Zaragoza, Spain; St Petersburg, Boston, United States Of America)
|  |
Longitudinal deteriorations in patient centered versus physiological measurements in patients with COPD
T. Oga, K. Nishimura, M. Tsukino, S. Sato, T. Hajiro, M. Mishima (Kyoto, Hikone, Otsu, Japan)
| |
Hyperinflation in GOLD 2 COPD
G. Wesseling, K. Walraven, B. Bleijlevens, E. F. M. Wouters (Maastricht, Netherlands)
| |
Respiratory factors associated with dyspnea in women with COPD
J. P. de Torres, C. Casanova, A. Montejo de Garcini, A. Aguirre-Jaime, B. R. Celli (Santa Cruz, Spain; Boston, United States Of America)
| |
Validity and reliability of the symptom domain of the clinical COPD questionnaire (CCQ)
J. W. H. Kocks, F. Koopmans, S. M. Uil, J. W. K. van den Berg, T. van der Molen (Groningen, Zwolle, Netherlands)
| |
The 6-minute walking distance parameters in COPD patients during biennium research
J. A. Mikryukova, G. V. Ashyrov, G. L. Ignatova, L. A. Stepanisheva, L. M. Chusova (Chelyabinsk, Russian Federation)
| |
Hoover‘s sign predicts expiratory flow limitation in chronic obstructive pulmonary disease (COPD)
M. Bruyneel, C. Sanida, C. Defrance, O. Bauwens, S. Abdel Kafi, R. Sergysels, V. Ninane (Brussels, Belgium)
| |
How exactly can we predict the prognosis of COPD?
S. Atis, A. Kanik, E. Ozgur, S. Eker, M. Tumkaya (Mersin, Turkey)
| |
Peak expiratory flow value and relationships between functional parameters in COPD
N. Komus, C. Sevinc, S. Ozalevli, H. Ellidokuz (Izmir, Turkey)
| |
The stage of severity, BODE-index and quality of life (QL) at COPD
I. N. Trofimenko, B. A. Chernyak (Irkutsk, Russian Federation)
| |
Using different pulmonary function parameters for establising reversibility in COPD patients
E. Saritas, M. Calikoglu, E. Ozgur, B. Ulubas, C. Ozge, A. Kanik (Mersin, Chest, Turkey)
| |
Symptom questionnaire and laboratory findings in COPD patients diagnosed by spirometry in Korea
K. S. Jung, K. S. Eom, Y. B. Park, S. H. Jang, S. M. Park, M. G. Lee, I. G. Hyun, H. S. Chung (Gyeonggi-do, Anyang-si, Seoul, Republic Of Korea)
| |
Predictor factors of mortality in COPD patients
N. Reyes, M. Merino, I. Alfageme, J. Lima, F. Pichardo (Seville, Spain)
| |
Quality of life (QOL) and clinical phenotypes in COPD
H. Makita, Y. Nasuhara, T. Betsuyaku, M. Nishimura, Hokkaido COPD Cohort Study Group (Sapporo, Japan)
| |
Correlations between SGRQ and other clinical and functional parameters in COPD patients
N. Bisca, R. Nemes, D. Ionita, M. Bisca (Bucharest, Romania)
| |
Effect of airway bacterial load and microbial patterns on dyspnea, exercise performance and health status in patients with stable COPD
S. Atis, E. S. Ozgur, M. Tumkaya, C. Ozge, N. Delialioglu (Mersin, Turkey)
| |
"INSPIRAÇÃO" study: the COPD patients perspective – a self description of COPD in secondary and primary care in Portugal
J. Cardoso, C. Barbara, R. Costa (Lisbon, Porto, Portugal)
| |
"INSPIRAÇÃO" study: a self description of severity, burden and health status in COPD patients in Portugal
J. Cardoso, C. Barbara, R. Costa (Lisboa, Porto, Portugal)
| |
Assessment of the relationship between FEF25-75/FVC ratio and reversibility in COPD
E. Coskun, E. Kaya, A. Sakar, P. Celik, A. Yorgancioglu (Manisa, Turkey)
| |
Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE)
J. Vestbo, C. Harvey, D. Ffyona, L. David, M. William, S. Edwin, on Behalf of the ECLIPSE Investigators (Copenhagen, Denmark; Vancouver, Canada; London, Cambridge, Edinburgh, United Kingdom; Boston, United States Of America)
| |